Skip to main content

Biotech firm developing Alzheimer's treatment announces terms for upcoming IPO

Pittsburgh-founded company is developing therapies for Alzheimer's.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.